Received Feb 25, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Z012120 | — |
no adverse event; Customer called to report TE.; This Spontaneous report was received from Other health professional and referred to a patient of unknown age and gender. The patient's medical history was not reported. The patient's past medications were not reported. The patient's concomitant medications were not reported. On 12-Feb-2026, the patient started therapy with Varicella Virus Vaccine Live (Oka-Merck) lyophilisate and solvent for solution for injection (VARIVAX)(Batch/Lot Number: Z012120, Expiration date: 23-Jul-2027) Injection reconstituted with sterile diluent Solution for injection for the treatment of prophylaxis (Unknown Batch/Lot Number). The vaccine underwent temperature excursion. (Temperature -14°C up to -10°C (-13.6 C) for 2 hours 5 minutes). There were no previous temperature excursion. No adverse event was reported.
MERCK STERILE DILUENT